Department of Biochemistry and Medical Biotechnology, Calcutta School of Tropical Medicine, 108, C.R. Avenue, Kolkata, 700 073, India.
Department of Microbiology, Calcutta School of Tropical Medicine, 108, C.R. Avenue, Kolkata, 700 073, India.
World J Microbiol Biotechnol. 2020 Jul 26;36(9):129. doi: 10.1007/s11274-020-02905-3.
Carbapenemase-mediated carbapenem resistance is a major public health concerns worldwide. In the present study, prevalence of circulating carbapenemases was estimated among carbapenem-resistant clinical isolates using PCR and sequencing. Diameters of zone of inhibition (ZDs) were compared for imipenem, meropenem and ertapenem among single carbapenemase producing isolates. Structure-based functional fitness of those carbapenemases was predicted through several in silico analyses. Approximately, 63.76% isolates demonstrated carbapenem resistance, of which 39.13% harboured carbapenemases like bla (33.23%), bla-like (0.31%), bla (4.35%), bla (4.04%), bla (6.85%), bla (16.50%), bla (3.88%), bla (2.91%) and bla (1.94%). Omega values indicated selection pressure over bla, bla and bla. Protein structural dynamics predicted NDM-1 and KPC-2 to have the highest and least flexibility, indicating differences in β-lactam binding and catalytic efficiency. Increased requirement of free folding energy, improved solvent accessibility and decreased melting temperatures among NDM-1-like, OXA-181, OXA-66, OXA-69 and OXA-104 predicted functional improvement over their ancestral variants. NDM-1-like carbapenemases demonstrated improvement in binding stability, affinity and catalysis of meropenem than that of NDM-1. Catalytic activity of imipenem was predicted to improve among OXA-181, which could be correlated with more than 1.5 folds smaller ZDs around imipenem disc, than that of meropenem/ertapenem, among OXA-181 producing isolates. However, OXA-66 indicated greater binding stability and affinity for imipenem and meropenem. This study indicated structural/functional convergence as well as divergence among several carbapenemase variants and provided useful insights into carbapenemase-mediated carbapenem resistance that might help in identifying appropriate treatment regimen for bacterial infections.
碳青霉烯酶介导的碳青霉烯类耐药性是全球主要的公共卫生关注点。在本研究中,使用 PCR 和测序技术估计了临床分离的碳青霉烯类耐药菌中循环碳青霉烯酶的流行率。对单一碳青霉烯酶产生菌的亚胺培南、美罗培南和厄他培南的抑菌圈直径(ZDs)进行了比较。通过几种基于结构的计算机分析预测了这些碳青霉烯酶的功能适应性。大约 63.76%的分离株表现出碳青霉烯类耐药性,其中 39.13%携带碳青霉烯酶,如 bla(33.23%)、bla-like(0.31%)、bla(4.35%)、bla(4.04%)、bla(6.85%)、bla(16.50%)、bla(3.88%)、bla(2.91%)和 bla(1.94%)。Omega 值表明 bla、bla 和 bla 受到选择压力。蛋白质结构动力学预测 NDM-1 和 KPC-2 的灵活性最高和最低,这表明在β-内酰胺结合和催化效率方面存在差异。NDM-1 样、OXA-181、OXA-66、OXA-69 和 OXA-104 的自由折叠能需求增加、溶剂可及性提高和熔点降低,表明它们的功能比其祖先变体有所提高。与 NDM-1 相比,NDM-1 样碳青霉烯酶对美罗培南的结合稳定性、亲和力和催化作用有所提高。OXA-181 的亚胺培南催化活性预计会提高,这可能与 OXA-181 产生菌中 OXA-181 周围的亚胺培南纸片的抑菌圈直径比美罗培南/厄他培南小 1.5 倍以上有关。然而,OXA-66 对亚胺培南和美罗培南的结合稳定性和亲和力更高。本研究表明,几种碳青霉烯酶变体之间存在结构/功能趋同和趋异,并为碳青霉烯酶介导的碳青霉烯类耐药性提供了有用的见解,这可能有助于确定细菌感染的适当治疗方案。